Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Interest Expenses (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Interest Expenses data on record, last reported at $2.7 million in Q3 2025.

  • For Q3 2025, Interest Expenses rose 0.51% year-over-year to $2.7 million; the TTM value through Sep 2025 reached $11.0 million, down 8.67%, while the annual FY2024 figure was $11.5 million, 14.76% down from the prior year.
  • Interest Expenses reached $2.7 million in Q3 2025 per GOSS's latest filing, roughly flat from $2.7 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.5 million in Q1 2023 and bottomed at $2.7 million in Q3 2024.
  • Average Interest Expenses over 4 years is $3.1 million, with a median of $3.2 million recorded in 2023.
  • Peak YoY movement for Interest Expenses: grew 0.95% in 2023, then decreased 18.22% in 2024.
  • A 4-year view of Interest Expenses shows it stood at $3.5 million in 2022, then dropped by 6.31% to $3.2 million in 2023, then decreased by 15.47% to $2.7 million in 2024, then rose by 0.37% to $2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $2.7 million in Q3 2025, $2.7 million in Q2 2025, and $2.7 million in Q1 2025.